Plain-English translation of NCT04916132 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The PRIMETIME study is investigating why some people with type 2 diabetes develop kidney disease. Researchers will take a small kidney tissue sample (through a biopsy) and collect blood, urine, and stool samples from 300 participants. These samples will be studied using advanced technology to find patterns that could help doctors diagnose kidney disease earlier and create personalized treatment plans.
Kidney disease is one of the most serious complications of type 2 diabetes, but doctors don't fully understand why it develops in some people and not others. This study aims to discover the underlying causes and biological markers so treatment can be tailored to each person's specific situation.
You likely qualify if…
You likely don't qualify if…
You will undergo a kidney biopsy, where doctors use a needle to collect a small tissue sample from your kidney. You'll also provide blood, urine, and stool samples for laboratory analysis. After the biopsy, you'll rest in the hospital for several hours to make sure there are no complications. You'll then be followed for up to 20 years with periodic check-ins to track your kidney health and disease progression.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Denmark